Vertex Pharma shares surge 26% after cystic fibrosis study results leaves Wall Street ‘speechless’

Shares of Vertex Pharmaceuticals surged more than 26 percent at the open of trading Wednesday, as the drugmaker crushed Wall Street’s expectations when it reported an improved response in patients suffering from cystic fibrosis. The biotech told CNBC on Tuesday...